Jim Cramer's 'Mad Money' Recap: 10 to Hold the Rest of the Year

Tickers in this article: AMZN BIIB CBS CELG CY DNKN FB FMI FUEL GILD JPM LNKD MAKO NAT NDLS NFLX OPK PCLN REGN SIRI TSLA XEC
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


NEW YORK (TheStreet) -- With just three trading days left in the quarter, Jim Cramer told his "Mad Money" viewers Thursday that the age-old tradition of money managers padding their portfolios with the "anointed" hot stocks for the year has begun.

With a government shutdown looming, Cramer said the following 10 stocks can be bought on weakness heading into the end of the year.

Cramer previously highlighted the first four names on the list, the biotech giants that every money manager has to show they own: Biogen Idec , Celgene , Regeneron and Gilead Sciences .

Next on the list is LinkedIn , the only social networking company with accelerating revenue growth that continues to surprise Wall Street.

Then there are the "cult" stocks of Amazon.com , Netflix and Tesla Motors . Cramer said these three stocks have valuations that defy logic, but no one seems to care.

Last on the list are Priceline.com and Facebook , a stock Cramer owns for his charitable trust, Action Alerts PLUS. Cramer said Priceline continues to benefit from the uptick in the global economy, while every money manager has to show they're smart enough to own Facebook.

Know Your IPO

The initial public offering market continues to be on fire, Cramer told viewers in his "Know Your IPO" segment. With the average return for IPOs in 2013 eclipsing 36%, Cramer said there are a few upcoming deals investors should be trying to get in on. Just as Foundation Medical and Rocket Fuel doubled on their first day, Cramer said these upcoming deals should be equally appealing.

Next week's deals include realtor ReMax and retailer Burlington Coat Factory. Cramer said he's not excited about either of these deals, but can't wait to pick up shares of Pot Belly, a regional restaurant chain with 280 locations in 18 states. Pot Belly may not have the most healthy of menus, Cramer admitted, but the regional to national growth story is one Wall Street just can't pass up. With shares expected to price between $9 and $11 a share, Cramer blessed owning Pot Belly up to $15 a share.